Data Further Validates Psilocybin as a Drug Candidate for Obesity and Supports Development of NeonMind's Drug Programs NEO-001 and NEO-002OAKVILLE, ON / ACCESSWIRE / March 23, 2022 / NeonMind Biosciences
NeonMind CEO Provides Update on the Progress of its Psilocybin Drug Development Research Plan and Team streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NeonMind Biosciences Inc: NeonMind CEO Provides Update on the Progress of its Psilocybin Drug Development Research Plan and Team finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.